Arkema SA Valuation
| ARKAY Stock | USD 79.24 1.06 1.36% |
At this time, the firm appears to be overvalued. Arkema SA ADR shows a prevailing Real Value of $57.85 per share. The current price of the firm is $79.24. Our model approximates the value of Arkema SA ADR from analyzing the firm fundamentals such as Profit Margin of 0.09 %, current valuation of 8.73 B, and Return On Equity of 0.15 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Arkema SA's price fluctuation is very steady at this time. Calculation of the real value of Arkema SA ADR is based on 3 months time horizon. Increasing Arkema SA's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Arkema SA is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Arkema Pink Sheet. However, Arkema SA's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 79.24 | Real 57.85 | Hype 79.24 | Naive 75.75 |
The intrinsic value of Arkema SA's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Arkema SA's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Arkema SA ADR helps investors to forecast how Arkema pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Arkema SA more accurately as focusing exclusively on Arkema SA's fundamentals will not take into account other important factors: Arkema SA Total Value Analysis
Arkema SA ADR is presently forecasted to have takeover price of 8.73 B with market capitalization of 7.51 B, debt of 2.56 B, and cash on hands of 1.34 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Arkema SA fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
8.73 B | 7.51 B | 2.56 B | 1.34 B |
Arkema SA Investor Information
The company has price-to-book (P/B) ratio of 0.82. Some equities with similar Price to Book (P/B) outperform the market in the long run. Arkema SA ADR has Price/Earnings To Growth (PEG) ratio of 0.77. The entity recorded earning per share (EPS) of 15.24. The firm last dividend was issued on the 19th of May 2022. Arkema SA had 374:361 split on the 20th of November 2014. Based on the key measurements obtained from Arkema SA's financial statements, Arkema SA ADR is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Arkema SA Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Arkema SA has an asset utilization ratio of 77.38 percent. This suggests that the Company is making $0.77 for each dollar of assets. An increasing asset utilization means that Arkema SA ADR is more efficient with each dollar of assets it utilizes for everyday operations.Arkema SA Ownership Allocation
Arkema SA holds a total of 74.81 Million outstanding shares. Almost 99.97 percent of Arkema SA outstanding shares are held by general public with 0.03 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Arkema SA Profitability Analysis
The company reported the revenue of 9.52 B. Net Income was 1.31 B with profit before overhead, payroll, taxes, and interest of 2.14 B.About Arkema SA Valuation
Our relative valuation model uses a comparative analysis of Arkema SA. We calculate exposure to Arkema SA's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Arkema SA's related companies.Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema ADR operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 19441 people.
8 Steps to conduct Arkema SA's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Arkema SA's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Arkema SA's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Arkema SA's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Arkema SA's revenue streams: Identify Arkema SA's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Arkema SA's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Arkema SA's growth potential: Evaluate Arkema SA's management, business model, and growth potential.
- Determine Arkema SA's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Arkema SA's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Arkema SA Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 75.9 M | |
| Quarterly Earnings Growth Y O Y | -0.095 | |
| Forward Price Earnings | 9.1158 | |
| Retained Earnings | 3.6 B |
Additional Tools for Arkema Pink Sheet Analysis
When running Arkema SA's price analysis, check to measure Arkema SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema SA is operating at the current time. Most of Arkema SA's value examination focuses on studying past and present price action to predict the probability of Arkema SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arkema SA's price. Additionally, you may evaluate how the addition of Arkema SA to your portfolios can decrease your overall portfolio volatility.